|
Gene: VPS50 |
Gene summary for VPS50 |
Gene summary. |
Gene information | Species | Human | Gene symbol | VPS50 | Gene ID | 55610 |
Gene name | VPS50 subunit of EARP/GARPII complex | |
Gene Alias | CCDC132 | |
Cytomap | 7q21.2-q21.3 | |
Gene Type | protein-coding | GO ID | GO:0006810 | UniProtAcc | Q96JG6 |
Top |
Malignant transformation analysis |
Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
Malignant transformation involving gene list. |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
55610 | VPS50 | CCI_1 | Human | Cervix | CC | 1.42e-06 | 6.32e-01 | 0.528 |
55610 | VPS50 | CCI_2 | Human | Cervix | CC | 1.33e-06 | 5.93e-01 | 0.5249 |
55610 | VPS50 | CCI_3 | Human | Cervix | CC | 7.97e-04 | 4.30e-01 | 0.516 |
55610 | VPS50 | LZE4T | Human | Esophagus | ESCC | 1.79e-04 | 1.83e-01 | 0.0811 |
55610 | VPS50 | LZE20T | Human | Esophagus | ESCC | 1.84e-03 | 1.56e-01 | 0.0662 |
55610 | VPS50 | LZE24T | Human | Esophagus | ESCC | 2.88e-08 | 2.13e-01 | 0.0596 |
55610 | VPS50 | P2T-E | Human | Esophagus | ESCC | 3.32e-16 | 2.55e-01 | 0.1177 |
55610 | VPS50 | P4T-E | Human | Esophagus | ESCC | 9.06e-05 | 1.77e-01 | 0.1323 |
55610 | VPS50 | P5T-E | Human | Esophagus | ESCC | 3.97e-03 | 4.37e-02 | 0.1327 |
55610 | VPS50 | P8T-E | Human | Esophagus | ESCC | 1.56e-10 | 1.71e-01 | 0.0889 |
55610 | VPS50 | P10T-E | Human | Esophagus | ESCC | 3.05e-06 | 1.42e-01 | 0.116 |
55610 | VPS50 | P11T-E | Human | Esophagus | ESCC | 1.52e-02 | 2.18e-01 | 0.1426 |
55610 | VPS50 | P12T-E | Human | Esophagus | ESCC | 3.82e-16 | 2.60e-01 | 0.1122 |
55610 | VPS50 | P15T-E | Human | Esophagus | ESCC | 2.44e-11 | 2.65e-01 | 0.1149 |
55610 | VPS50 | P16T-E | Human | Esophagus | ESCC | 7.56e-26 | 5.08e-01 | 0.1153 |
55610 | VPS50 | P17T-E | Human | Esophagus | ESCC | 2.49e-07 | 3.25e-01 | 0.1278 |
55610 | VPS50 | P20T-E | Human | Esophagus | ESCC | 3.96e-18 | 3.87e-01 | 0.1124 |
55610 | VPS50 | P21T-E | Human | Esophagus | ESCC | 9.85e-09 | 2.02e-01 | 0.1617 |
55610 | VPS50 | P22T-E | Human | Esophagus | ESCC | 4.34e-12 | 1.04e-01 | 0.1236 |
55610 | VPS50 | P23T-E | Human | Esophagus | ESCC | 1.49e-13 | 3.37e-01 | 0.108 |
Page: 1 2 3 4 |
Transcriptomic changes along malignancy continuum. |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
Figure of enriched GO biological processes. |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | |
Colorectum | SER | |
Colorectum | MSS | |
Colorectum | MSI-H | |
Colorectum | FAP |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
Enriched GO biological processes. |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00988767 | Cervix | CC | vesicle-mediated transport to the plasma membrane | 34/2311 | 136/18723 | 3.75e-05 | 5.91e-04 | 34 |
GO:00161977 | Cervix | CC | endosomal transport | 48/2311 | 230/18723 | 1.65e-04 | 1.97e-03 | 48 |
GO:001619715 | Esophagus | ESCC | endosomal transport | 168/8552 | 230/18723 | 2.28e-17 | 1.93e-15 | 168 |
GO:009887615 | Esophagus | ESCC | vesicle-mediated transport to the plasma membrane | 99/8552 | 136/18723 | 1.13e-10 | 3.39e-09 | 99 |
GO:00324565 | Esophagus | ESCC | endocytic recycling | 51/8552 | 73/18723 | 2.47e-05 | 2.10e-04 | 51 |
GO:001619718 | Thyroid | PTC | endosomal transport | 128/5968 | 230/18723 | 6.26e-14 | 3.52e-12 | 128 |
GO:009887618 | Thyroid | PTC | vesicle-mediated transport to the plasma membrane | 74/5968 | 136/18723 | 4.20e-08 | 9.08e-07 | 74 |
GO:001619719 | Thyroid | ATC | endosomal transport | 128/6293 | 230/18723 | 4.44e-12 | 1.75e-10 | 128 |
GO:009887619 | Thyroid | ATC | vesicle-mediated transport to the plasma membrane | 77/6293 | 136/18723 | 2.86e-08 | 5.43e-07 | 77 |
Page: 1 |
Enriched KEGG pathways. |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
Annotation of somatic variants for genes involved in malignant transformation |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
VPS50 | SNV | Missense_Mutation | c.2300N>A | p.Ser767Tyr | p.S767Y | Q96JG6 | protein_coding | tolerated(0.06) | probably_damaging(0.993) | TCGA-AA-A010-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Chemotherapy | folinic | CR | |
VPS50 | SNV | Missense_Mutation | novel | c.1157N>A | p.Arg386Gln | p.R386Q | Q96JG6 | protein_coding | deleterious(0.01) | probably_damaging(0.968) | TCGA-AZ-4315-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
VPS50 | SNV | Missense_Mutation | c.436N>A | p.Ala146Thr | p.A146T | Q96JG6 | protein_coding | tolerated(0.08) | benign(0.04) | TCGA-AZ-6598-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
VPS50 | SNV | Missense_Mutation | c.2255C>T | p.Ala752Val | p.A752V | Q96JG6 | protein_coding | tolerated(0.5) | benign(0.187) | TCGA-AZ-6601-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
VPS50 | SNV | Missense_Mutation | rs768307939 | c.2512N>T | p.Arg838Cys | p.R838C | Q96JG6 | protein_coding | tolerated(0.14) | probably_damaging(0.995) | TCGA-CA-6718-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | PD |
VPS50 | SNV | Missense_Mutation | c.62N>T | p.Ser21Ile | p.S21I | Q96JG6 | protein_coding | tolerated_low_confidence(0.19) | benign(0.001) | TCGA-D5-6924-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
VPS50 | SNV | Missense_Mutation | rs371166383 | c.1118N>A | p.Arg373His | p.R373H | Q96JG6 | protein_coding | deleterious(0.03) | possibly_damaging(0.902) | TCGA-F4-6805-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Chemotherapy | xeloda | CR |
VPS50 | SNV | Missense_Mutation | c.1826N>G | p.Asn609Ser | p.N609S | Q96JG6 | protein_coding | deleterious(0) | probably_damaging(0.931) | TCGA-QG-A5YV-01 | Colorectum | colon adenocarcinoma | Female | <65 | III/IV | Chemotherapy | xeloda | CR | |
VPS50 | SNV | Missense_Mutation | c.2026C>G | p.Leu676Val | p.L676V | Q96JG6 | protein_coding | tolerated(0.09) | benign(0.112) | TCGA-QL-A97D-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
VPS50 | SNV | Missense_Mutation | rs867866841 | c.2570G>A | p.Arg857Gln | p.R857Q | Q96JG6 | protein_coding | tolerated(0.24) | probably_damaging(0.979) | TCGA-AG-A002-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 |
Top |
Related drugs of malignant transformation related genes |
Identification of chemicals and drugs interact with genes involved in malignant transfromation |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |